| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/03/2011 | CN102139032A Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease |
| 08/03/2011 | CN102139031A Mongolian medicine for treating bone fracture and strengthening bones |
| 08/03/2011 | CN102139027A Medicinal liquor for treating rheumatic arthritis |
| 08/03/2011 | CN102139022A Medicament for treating lumbar intervertebral disc protrusion and rheumatism |
| 08/03/2011 | CN102139011A Traditional Chinese medicine prescription for treating various bone and joint diseases |
| 08/03/2011 | CN102139007A Formula of pure traditional Chinese medicine for treating senile osteoporosis and decoction-free granules |
| 08/03/2011 | CN102139004A Plaster for treating gout disease and application thereof |
| 08/03/2011 | CN102139003A Plaster for treating furuncle and joint swelling and heat and application thereof |
| 08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
| 08/03/2011 | CN102138993A Hyperosteogeny ointment |
| 08/03/2011 | CN102138986A Medicated bath material for treating rheumatism and gout and preparation method thereof |
| 08/03/2011 | CN102138961A Application of black bean peel extract in products for preventing and treating osteoarthritis |
| 08/03/2011 | CN102138952A Herbal grace osteophyte pain relieving spirits |
| 08/03/2011 | CN102138951A Preparation method of gynura japonica alkaloid |
| 08/03/2011 | CN102138938A Composition for preparing products for improving hyperuricemia |
| 08/03/2011 | CN102138921A Application of phthalimide derivatives to preparation of anti-angiogenesis medicaments |
| 08/03/2011 | CN102138905A RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 08/03/2011 | CN101837115B Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc |
| 08/03/2011 | CN101787000B M-stage kinesin inhibitor |
| 08/03/2011 | CN101690797B Traditional Chinese medicine for treating rheumatism and rheumatoid diseases |
| 08/03/2011 | CN101690779B Traditional Chinese medicine for oral taking for treating scapulohumeral periarthritis |
| 08/03/2011 | CN101664476B Medicinal pillow |
| 08/03/2011 | CN101495632B Humanized anti-human osteopontin antibody |
| 08/03/2011 | CN101474315B Effective component group of stem-bark or root-bark of Daphne giraldii as well as preparation method and use thereof |
| 08/03/2011 | CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989620 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | CA2608890C Heterobicyclic metalloprotease inhibitors |
| 08/02/2011 | CA2507262C Pharmaceutical composition containing bakuchiol for treating female osteoporosis |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2417984C Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2364451C Agent for treatment of arthritic disease |
| 07/28/2011 | WO2011091401A2 Treatment of immune disorders using kainate receptor antagonists |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011059326A3 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers |
| 07/28/2011 | WO2011056037A9 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 07/28/2011 | WO2010140061A3 Formulations for the treatment of deep tissue pain |
| 07/28/2011 | WO2010083034A9 Methods for increasing adiponectin |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184026 C4-substituted alpha-keto oxazoles |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110184011 Compounds |
| 07/28/2011 | US20110184001 Inhibitors of bruton's tyrosine kinase |
| 07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 07/28/2011 | US20110183984 Small molecule inhibitors of lck sh2 domain binding |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183967 Benzoxazole compounds and methods of use |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183936 Regimens for intra-articular viscosupplementation |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183889 Salicylanilide modified peptides for use as oral therapeutics |
| 07/28/2011 | US20110183886 Melanocortin receptor ligands |
| 07/28/2011 | US20110183008 Lactoferrin |
| 07/28/2011 | US20110183006 Compositions and methods for treating osteoarthritis |
| 07/28/2011 | US20110182995 Medical and dental biomaterial and method of use for the same |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182985 Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
| 07/28/2011 | US20110182963 Osteoimplant and methods for making |
| 07/28/2011 | US20110182961 Osteogenic cell delivery matrix |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | US20110182950 Combination of blood and of biphasic calcium phosphate ceramic particles |
| 07/28/2011 | US20110182922 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 07/28/2011 | US20110182916 Use of Agonists of Integrin Alpha 5 for Inducing the Osteogenic Differentiation of Mesenchymal Stem Cells |
| 07/28/2011 | US20110182915 Therapeutic agent or preventive agent for osteoarthritis |
| 07/28/2011 | US20110182913 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182904 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182883 Novel gene disruptions, compositions and methods relating thereto |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/27/2011 | EP2348114A1 Bone delivery conjugates and method of using same to target proteins to bone |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348043A1 APO-2 ligand variants and uses thereof |
| 07/27/2011 | EP2347771A1 Peptide-based compounds for targeted imaging |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |
| 07/27/2011 | EP2346864A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| 07/27/2011 | EP2346857A2 Compounds for the treatment of inflammatory disorders |
| 07/27/2011 | EP2346846A1 Anhydrate and hydrate forms of strontium ranelate |
| 07/27/2011 | EP2346844A1 Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders |
| 07/27/2011 | EP2346824A1 Novel estrogen receptor ligands |
| 07/27/2011 | EP2346512A1 Composition for prevention and treatment of allergic and/or inflammatory diseases |
| 07/27/2011 | EP1601646B1 2-substituted vitamin d analogues and their therapeutic uses |